Skip to content


More than 1,000 eye care professionals worldwide have been using the AdaptDx® and AdaptDx Pro® to test for impaired dark adaptation, the earliest biomarker of age-related macular degeneration. Our customers tell the story of how they’re fighting against preventable blindness by identifying AMD at its earliest stages and closely monitoring its progression. 

The MacuLogix AdaptDx performs a robust and reliable test of central retinal function and helps identify an early biomarker for age-related macular degeneration. The elegance of the instrument lies in its simplicity: an easy procedure for the patient, a short test duration, and an unambiguous data output for the clinician.

LarryBaitch Larry Baitch, OD

The AdaptDx has been a wonderful addition to our practice. Not only does it allow us to help detect macular degeneration at its earliest subclinical state, but also allows us to help educate patients about lifestyle changes. The whole goal is to delay advancement of the disease and improve the quality of living. It has been a wonderful practice builder by setting us apart as a very high-quality eye care facility providing better patient confidence in the care that they are being provided.

MichaelFishbaugh Michael Fishbaugh, OD

Using the AdaptDx, doctors can help patients with one of the most feared conditions and provide them hope and early treatment options.

Paul M. Karpecki, OD, FAAO Paul Karpecki, OD

I am excited that my practice can now work toward the goal of eliminating vision loss from macular degeneration by proactively identifying this disease early and providing earlier intervention for our patients. Our AdaptDx sits next to our visual field and OCT. Our practice is now prepared to identify and manage macular degeneration the same way we do glaucoma.

RyanPowell Ryan Powell, OD

The MacuLogix AdaptDx dark adaptometer is the first device of its kind that will provide me with a quantifiable result that can be monitored over time. It allows me to track the function of a patient’s macular rod photoreceptors, which is a very specific biomarker for AMD. In my opinion, this device is a game-changer in any practice committed to preserving sight. Having the ability to diagnose AMD in patients with symptoms but little to no clinical signs has taken my confidence to the next level.

TimothyEarley (2) Timothy Earley, OD

Equipment companies usually ship you a big box and you never hear from them again. That was not the case with MacuLogix and their AdaptDx. They spent 2 days with us and did a fantastic job training our whole office!

Julia Blank OD Julia Blank, OD

I strongly believe that if we can catch AMD at a very early stage – and proactively recommend supplements, blue light filters, sunglasses, plus tell them to watch their BMI and cholesterol levels – we can stop or slow this down and help preserve their vision.

Laurie Sorrenson, OD, FAAO Laurie Sorrenson, OD, FAAO

Thanks to the comprehensive AMD Excellence training program from MacuLogix, each staff member - from the front desk and optical, to technicians and billing - understands the important role they play in AMD care.

R. Aaron Werner Aaron Werner, OD

After learning the specifics about pre-clinical macular degeneration and the opportunity I have to identify this devastating disease in my patients much earlier than ever before, it was a no-brainer that all my patients with risk factors or over the age of 50 must have the AdaptDx test done.

RyanPowell Ryan Powell, OD

AdaptDx more than paid for itself within the first few months.

Tammy Tully 2 Tammy Tully, OD